VIDA

company

About

VIDA is modernizing lung and respiratory care through intelligence

  • 51 - 100

Details

Last Funding Type
Series C
Last Funding Money Raised
$11M
Industries
Artificial Intelligence,Biotechnology,Health Care,Health Diagnostics,Medical,Medical Device
Founded date
Jan 1, 2004
Number Of Employee
51 - 100
Operating Status
Active

VIDA modernizes lung and respiratory care, empowering healthcare organizations and physicians to improve patient outcomes, streamline care coordination and drive efficiencies through a comprehensive approach, proven quality, and clinical leadership. Through quantitative data intelligence and impactful visualizations, VIDA helps physicians manage patients with or at risk of chronic obstructive pulmonary disease (COPD), interstitial lung disease (ILD), lung cancer, and now, COVID-19. VIDA’s software is FDA cleared, CE-marked, Health Canada licensed and TGA registered for clinical use in the US, European Economic Area, Canada, and Australia. Learn more at vidalung.ai.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$16.60M
VIDA has raised a total of $16.60M in funding over 2 rounds. Their latest funding was raised on Mar 12, 2020 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 12, 2020 Series C $11M 1 Detail
May 21, 2019 Debt Financing $500K 1 Iowa Innovation Acceleration Fund Detail
Dec 20, 2016 Series B $5.10M 2 Detail

Investors

Number of Lead Investors
Number of Investors
1
4
VIDA is funded by 4 investors. Iowa Innovation Acceleration Fund and Iowa First Capital Fund are the most recent investors.
Investor Name Lead Investor Funding Round
Iowa Innovation Acceleration Fund Yes Debt Financing
Iowa First Capital Fund Series C
Iowa Seed Fund Series B
Northern California Investment Fund Series B